Status:

UNKNOWN

Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors

Lead Sponsor:

University Hospital Muenster

Collaborating Sponsors:

Deutsche Kinderkrebsstiftung

Hannover Medical School

Conditions:

Intracranial Germ Cell Tumors

Eligibility:

All Genders

Phase:

PHASE4

Brief Summary

STUDY DESIGN: Prospective, non-randomised multicentre study with patients stratified according to risk groups INVESTIGATIONAL MEDICINAL PRODUCTS The IMPs on this trial are Carboplatin, Cisplatin, Ifo...

Detailed Description

PATIENT POPULATION Age of patients: no lower or upper age limit; Estimated number: 400 malignant germ cell tumours Diagnosis and main criteria for inclusion/exclusion: Intracranial Germ Cell tumours...

Eligibility Criteria

Inclusion

  • Main residence in one of the participating countries
  • Primary diagnosis of an intracranial germ cell tumour
  • Written consent for trial participation, treatment according to the protocol and consent for data transfer

Exclusion

  • Tumour entity other than primary intracranial germ cell tumour or CNS GCT as second malignancy
  • Primary diagnosis pre-dating the opening of SIOP CNS GCT II in the participating country of registration
  • Medical, psychiatric or social conditions incompatible with trial treatment or treatment according to protocol is not intended
  • Participation within a different trial for treatment of germ cell tumours and/or concurrent treatment within any other clinical trial. The only exceptions to this are trials with different endpoints, involving aspects of supportive treatment which can run parallel to SIOP CNS GCT II without influencing the outcome of this trial e.g. trials on antiemetics, antimycotics, antibiotics, strategies for psychosocial support etc.
  • Pregnancy and lactation
  • Any treatment not given according to protocol prior to registration

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2018

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT01424839

Start Date

October 1 2011

End Date

October 1 2018

Last Update

June 4 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Muenster

Münster, Germany, 48129

Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumors | DecenTrialz